Equities

Jupiter Life Line Hospitals Ltd

Jupiter Life Line Hospitals Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)1,185.25
  • Today's Change19.80 / 1.70%
  • Shares traded13.08k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jun 07 2024 10:59 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Jupiter Life Line Hospitals Limited is an India-based holding company. The Company is engaged in providing services in the field of health care and related services. The Company is running multi-specialty Hospital of around 366 operational beds in Thane near Mumbai and 353 operational beds in Baner, Pune. It also has an approximately 231 operational beds hospital in Indore. It is equipped with over 30 specialty treatments, such as bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, gastroenterology, infectious diseases, internal medicine, mental health, nephrology, neurology, neurosurgery, and nutrition and dietetics. It has also set up Hotel in Thane under the name Fortune Park Lake City Hotel and with management collaboration with ITC group of hotels for promoting medical tourism. The Company's subsidiaries include Jupiter Hospital Projects Private Limited and Medulla Healthcare Private Limited.

  • Revenue in INR (TTM)10.70bn
  • Net income in INR1.77bn
  • Incorporated2002
  • Employees3.14k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Krsnaa Diagnostics Ltd6.20bn568.40m18.48bn2.56k32.852.2814.062.9817.4217.42190.03250.790.59534.634.97--5.466.726.688.5977.2482.559.1711.741.374.230.1648--27.2024.25-8.49--14.21--
Indraprastha Medical Corporation Ltd12.45bn1.24bn22.59bn2.95k18.224.7313.771.8113.5213.52135.7652.121.9566.2219.66--19.3912.7425.2117.0457.4957.379.966.731.8237.750.066429.1313.299.5743.8934.2632.3422.98
Artemis Medicare Services Ltd8.79bn491.41m23.89bn1.94k49.295.3326.712.723.543.5463.0232.750.93640.009.20--5.24--6.66------5.594.590.92082.950.4133--19.149.9627.3219.12----
Shalby Ltd9.34bn840.80m27.68bn2.68k33.192.7720.392.967.787.7886.2193.330.64642.407.44--5.784.827.065.5345.9063.928.948.200.98087.780.272719.1216.0115.1024.1921.578.3919.14
Thyrocare Technologies Ltd5.72bn707.70m32.42bn1.65k45.656.1527.825.6713.4113.41108.0899.520.89594.438.89--10.8918.1712.5520.9770.8569.8112.1519.562.5526.830.074383.568.587.269.94-3.638.88-2.09
Yatharth Hospital & Trauma Cre Srvcs Ltd6.70bn1.14bn35.58bn--26.934.0724.755.3115.3915.3991.17101.84----------11.27--13.7380.1478.5017.0812.307.4741.510.0883--28.8845.7874.0695.813.69--
Healthcare Global Enterprises Ltd19.08bn481.40m50.25bn5.50k105.176.0923.302.633.433.43136.1259.290.759621.966.40--1.65-2.262.26-3.0553.4053.782.17-3.500.85681.390.5956--12.8014.3564.03--0.0453--
Jupiter Life Line Hospitals Ltd10.70bn1.77bn77.14bn3.14k41.076.6035.237.2128.6528.65171.06178.300.94369.3920.79--15.58--17.39--82.28--16.51--3.677.430.00--19.83--142.25------
Vijaya Diagnostic Centre Ltd5.48bn1.19bn83.41bn2.00k70.2012.6747.2215.2311.5911.5953.4464.210.596718.1042.58--13.0314.1014.1415.5488.0586.4121.8421.202.836.830.2826.6619.3413.3740.4020.977.58--
Metropolis Healthcare Ltd12.08bn1.28bn97.68bn4.29k76.638.9143.828.0924.8824.88235.10213.970.79026.159.73--8.4013.6510.1116.9478.7975.7310.6414.661.138.350.152--5.189.67-10.541.2521.84--
Rainbow Children's Medicare Ltd12.97bn2.17bn132.02bn3.58k60.8410.4939.9610.1821.3821.38127.78124.030.65817.7321.29--11.089.8911.9910.9687.2683.5116.8313.804.005.360.377--10.5119.032.9337.2332.22--
Krishna Institute Of Medical Sciencs Ltd24.98bn3.10bn146.15bn10.00k47.127.9930.285.8538.7638.76312.20228.460.735511.499.13--9.9013.7112.2016.7378.7761.4213.4615.531.1010.440.393--13.6722.17-7.78--52.94--
Data as of Jun 07 2024. Currency figures normalised to Jupiter Life Line Hospitals Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

12.34%Per cent of shares held by top holders
HolderShares% Held
SBI Funds Management Ltd.as of 30 Apr 20245.30m8.09%
Axis Asset Management Co. Ltd.as of 30 Apr 2024780.00k1.19%
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 30 Apr 2024467.92k0.71%
Canara Robeco Asset Management Co. Ltd.as of 15 May 2024374.77k0.57%
Kotak Mahindra Asset Management Co. Ltd.as of 30 Apr 2024279.33k0.43%
WhiteOak Capital Asset Management Ltd.as of 30 Apr 2024208.71k0.32%
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 30 Apr 2024182.71k0.28%
Neuberger Berman Investment Advisers LLCas of 30 Apr 2024169.81k0.26%
Edelweiss Asset Management Ltd.as of 30 Apr 2024164.00k0.25%
Loomis, Sayles & Co. LPas of 28 Mar 2024163.26k0.25%
More ▼
Data from 31 Mar 2024 - 15 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.